D. Seidel

12.0k total citations · 2 hit papers
244 papers, 9.6k citations indexed

About

D. Seidel is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, D. Seidel has authored 244 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Surgery, 64 papers in Endocrinology, Diabetes and Metabolism and 59 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in D. Seidel's work include Lipoproteins and Cardiovascular Health (65 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers) and Cancer, Lipids, and Metabolism (28 papers). D. Seidel is often cited by papers focused on Lipoproteins and Cardiovascular Health (65 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (44 papers) and Cancer, Lipids, and Metabolism (28 papers). D. Seidel collaborates with scholars based in Germany, United States and United Kingdom. D. Seidel's co-authors include Heinrich Wieland, Victor W. Armstrong, Joachim Thiery, Autar K. Walli, Peter Cremer, R. H. Furman, Dorothea Nagel, P Stieber, Stefan Holdenrieder and P. Schuff‐Werner and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

D. Seidel

237 papers receiving 9.0k citations

Hit Papers

The association between serum Lp(a) concentrations and an... 1983 2026 1997 2011 1986 1983 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Seidel Germany 53 4.5k 2.1k 1.8k 1.8k 1.7k 244 9.6k
Lars Berglund United States 59 4.7k 1.0× 3.3k 1.6× 2.2k 1.3× 2.7k 1.5× 1.3k 0.8× 249 12.7k
Amos Pasternack Finland 45 3.3k 0.7× 2.3k 1.1× 1.6k 0.9× 1.5k 0.8× 725 0.4× 252 10.1k
Anton F. H. Stalenhoef Netherlands 64 6.3k 1.4× 4.1k 2.0× 2.9k 1.6× 2.8k 1.6× 1.7k 1.0× 240 13.3k
N.E. Miller United Kingdom 53 5.5k 1.2× 6.1k 2.9× 2.2k 1.2× 2.1k 1.2× 1.9k 1.2× 161 11.9k
Alberto Corsini Italy 54 5.3k 1.2× 1.5k 0.7× 1.7k 1.0× 3.0k 1.7× 1.6k 1.0× 294 10.5k
William Insull United States 43 3.9k 0.9× 1.2k 0.6× 2.4k 1.4× 1.7k 1.0× 1.2k 0.7× 140 11.2k
Vesa Manninen Finland 39 5.0k 1.1× 4.8k 2.3× 2.7k 1.5× 1.4k 0.8× 1.2k 0.7× 144 11.2k
Hiroshi Mabuchi Japan 60 6.7k 1.5× 4.5k 2.2× 4.1k 2.3× 2.7k 1.5× 1.9k 1.1× 390 13.0k
John R. Guyton United States 53 6.2k 1.4× 3.3k 1.6× 2.5k 1.4× 1.7k 1.0× 1.8k 1.1× 166 12.0k
Alexandros D. Tselepis Greece 46 3.2k 0.7× 2.1k 1.0× 1.5k 0.8× 1.3k 0.7× 983 0.6× 258 7.3k

Countries citing papers authored by D. Seidel

Since Specialization
Citations

This map shows the geographic impact of D. Seidel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Seidel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Seidel more than expected).

Fields of papers citing papers by D. Seidel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Seidel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Seidel. The network helps show where D. Seidel may publish in the future.

Co-authorship network of co-authors of D. Seidel

This figure shows the co-authorship network connecting the top 25 collaborators of D. Seidel. A scholar is included among the top collaborators of D. Seidel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Seidel. D. Seidel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seidel, D., et al.. (2010). Systematic review: the association between obesity and hepatocellular carcinoma – epidemiological evidence. Alimentary Pharmacology & Therapeutics. 31(10). 1051–1063. 80 indexed citations
2.
Teupser, Daniel, Joerg Koglin, Wolfgang Wilfert, et al.. (2007). CD36 mRNA EXPRESSION IS INCREASED IN CD14+ MONOCYTES OF PATIENTS WITH CORONARY HEART DISEASE. Clinical and Experimental Pharmacology and Physiology. 35(5-6). 552–556. 21 indexed citations
3.
Fraunberger, Peter, Ying Wang, Ernst Holler, et al.. (2006). PROGNOSTIC VALUE OF INTERLEUKIN 6, PROCALCITONIN, AND C-REACTIVE PROTEIN LEVELS IN INTENSIVE CARE UNIT PATIENTS DURING FIRST INCREASE OF FEVER. Shock. 26(1). 10–12. 90 indexed citations
4.
Jaeger, B.R., Frank M. Bengel, Kenichi Odaka, et al.. (2005). Changes in Myocardial Vasoreactivity After Drastic Reduction of Plasma Fibrinogen and Cholesterol: a Clinical Study in Long-term Heart Transplant Survivors Using Positron Emission Tomography. The Journal of Heart and Lung Transplantation. 24(12). 2022–2030. 9 indexed citations
5.
Seidel, D.. (2003). [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].. Zeitschrift für Kardiologie. 92.
6.
Vogeser, Michael, P. Knesewitsch, Karl Jacob, & D. Seidel. (1999). Evaluation of the First Automated Thyroglobulin Assay. Clinical Chemistry and Laboratory Medicine (CCLM). 37(2). 159–164. 10 indexed citations
7.
Jaeger, B.R., Peter Marx, Thomas Pfefferkorn, Gerhard F. Hamann, & D. Seidel. (1999). Heparin-Mediated Extracorporeal LDL/Fibrinogen Precipitation —H.E.L.P.-In Coronary and Cerebral Ischemia. PubMed. 73. 81–84. 10 indexed citations
8.
Thiery, Joachim & D. Seidel. (1998). Safety and effectiveness of long‐term LDL‐apheresis in patients at high risk. Current Opinion in Lipidology. 9(6). 521–526. 28 indexed citations
9.
Pilz, Georg, Roland Appel, E. Kreuzer, et al.. (1996). Bedeutung erhöhter TNF-Rezeptorspiegel bei herzchirurgischen Risikopatienten. Transfusion Medicine and Hemotherapy. 23(Suppl. 4). 29–34. 1 indexed citations
10.
Follmann, Hartmut, et al.. (1994). Characterization and Extracorporeal Application of a New Phosphate-Binding Agent. Clinical Chemistry and Laboratory Medicine (CCLM). 32(10). 733–9. 8 indexed citations
11.
Cremer, Peter, D. Nagel, Barbara Labrot, et al.. (1994). Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). European Journal of Clinical Investigation. 24(7). 444–453. 257 indexed citations
12.
Carlsson, J., Victor W. Armstrong, Hansotto Reiber, K. Felgenhauer, & D. Seidel. (1991). Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clinica Chimica Acta. 196(2-3). 167–176. 80 indexed citations
13.
Thiery, Joachim, C. Creutzfeldt, W. Creutzfeldt, Autar K. Walli, & D. Seidel. (1990). Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia. Journal of Molecular Medicine. 68(16). 814–822. 12 indexed citations
14.
Cremer, Peter, Rainer Muche, Birgit Kruse‐Lösler, D. Seidel, & Barbara Labrot. (1989). [Risk of myocardial infarct in 40 to 60-year-old males in relation to potential risk factors of atherosclerosis. Intermediate evaluation of the Göttingen risk, incidence and prevalence study following a 5-year observation period].. PubMed. 41(5). 154–62. 1 indexed citations
15.
Eisenhauer, T., Victor W. Armstrong, P. Schuff‐Werner, et al.. (1989). Long-term Clinical Experience with HELP-LDL-Apheresis in Combination with HMG-CoA-Reductase Inhibitors for Maximum Treatment of Coronary Heart Disease Associated with Severe Hypercholesterolemia. ASAIO Transactions. 35(3). 580–582. 6 indexed citations
16.
Armstrong, Victor W., et al.. (1988). Acute and long-term effects of low-density lipoprotein apheresis on the serum concentrations of vitamins E and A. Journal of Molecular Medicine. 66(3). 123–128. 14 indexed citations
17.
Cremer, Peter, Harald Elster, Barbara Labrot, et al.. (1988). Incidence rates of fatal and nonfatal myocardial infarction in relation to the lipoprotein profile: first prospective results from the Göttingen Risk, Incidence, and Prevalence Study (GRIPS).. PubMed. 66 Suppl 11. 42–9. 12 indexed citations
18.
Müller, Pierre, R. Fellin, Joeri Lambrecht, et al.. (1974). Hypertriglyceridaemia Secondary to Liver Disease. European Journal of Clinical Investigation. 4(6). 419–428. 28 indexed citations
19.
Seidel, D., Bruno Agostini, & Pierre Müller. (1972). Structure of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 260(1). 146–152. 76 indexed citations
20.
Seidel, D., H. P. Geisen, & D. Roelcke. (1971). Identification of the protein moiety of the LP(a)‐lipoprotein in human plasma. FEBS Letters. 18(1). 43–46. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026